trial · primary record
Temozolomide
Glioblastoma
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 2250 |
| Primary completion | 2030-06 |
| Primary endpoint | Overall Survival (OS) |
| Registry ID | NCT03970447 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:13.675Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03970447
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.